Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.880
-0.140 (-13.72%)
At close: Dec 20, 2024, 4:00 PM
0.895
+0.015 (1.68%)
After-hours: Dec 20, 2024, 7:55 PM EST
Applied Therapeutics Stock Forecast
APLT's stock price has decreased by -71.05% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for APLT stock have an average target of 6.10, with a low estimate of 1.50 and a high estimate of 14. The average target predicts an increase of 593.10% from the current stock price of 0.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for APLT stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +70.44% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +127.25% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +808.99% | Nov 29, 2024 |
| Baird | Baird | Buy Maintains $14 → $5 | Buy | Maintains | $14 → $5 | +468.12% | Nov 29, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +354.49% | Nov 29, 2024 |
Financial Forecast
Revenue This Year
544.27K
from 9.99M
Decreased by -94.55%
Revenue Next Year
15.05M
from 544.27K
Increased by 2,664.24%
EPS This Year
-1.49
from -1.42
EPS Next Year
-0.54
from -1.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 840,000 | 41.4M | 90.7M | |||
| Avg | 544,272 | 15.0M | 67.9M | |||
| Low | 446,880 | 766,360 | 46.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -91.6% | 7,501.0% | 503.1% | |||
| Avg | -94.6% | 2,664.2% | 351.2% | |||
| Low | -95.5% | 40.8% | 211.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.35 | -0.05 | 0.39 | |||
| Avg | -1.49 | -0.54 | -0.28 | |||
| Low | -1.76 | -0.70 | -0.58 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.